- Radiotherapy Duality in Metastatic Disease
- Reshuffle
- Dual Immune Checkpoint Blockade in Microsatellite Instability-High Cancers
- Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer
- Magnetic Resonance Imaging or Confirmatory Biopsy for Patients With Prostate Cancer Receiving Active Surveillance
- A Clinical Tool to Identify Incidental Meningioma for Early Outpatient Management
- Nivolumab and Ipilimumab Combination Treatment in Advanced dMMR/MSI-H Noncolorectal Cancers
- Semaglutide and Tirzepatide Prescribing in Patients With Preexisting Comorbid Cancers
- Zanidatamab in HER2-Positive Metastatic Biliary Tract Cancer
- Urinary Diversion After Cystectomy for Bladder Cancer
- Immune Checkpoint Inhibitor–Associated Cardiovascular Toxic Effects
- Ultraprocessed Food and Early-Onset Colorectal Cancer Precursors Among Women
- Details Regarding Pneumonitis With High-Dose Aumolertinib
- Medicaid Cuts and the Future of Cancer Care
- Another Feather in the Cap for Posttransplant Cyclophosphamide GVHD Prophylaxis?
